GW Pharmaceuticals (GW Pharmaceuticals) PB Ratio : 8.74 (As of Apr. 25, 2024)

View and export this data going back to . Start your Free Trial

What is GW Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-25), GW Pharmaceuticals's share price is $17.00. GW Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2021 was $1.95. Hence, GW Pharmaceuticals's PB Ratio of today is 8.74.

The historical rank and industry rank for GW Pharmaceuticals's PB Ratio or its related term are showing as below:

GWPRF' s PB Ratio Range Over the Past 10 Years
Min: 2.17 Med: 6.18 Max: 18.01
Current: 8.74

During the past 13 years, GW Pharmaceuticals's highest PB Ratio was 18.01. The lowest was 2.17. And the median was 6.18.

GWPRF's PB Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.945 vs GWPRF: 8.74

During the past 12 months, GW Pharmaceuticals's average Book Value Per Share Growth Rate was 1.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 16.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 5.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 31.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of GW Pharmaceuticals was 180.70% per year. The lowest was -37.00% per year. And the median was 9.90% per year.

Back to Basics: PB Ratio

GW Pharmaceuticals PB Ratio Historical Data

The historical data trend for GW Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GW Pharmaceuticals PB Ratio Chart

GW Pharmaceuticals Annual Data

Trend

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Dec19

Dec20

PB Ratio

Get a 7-Day Free Trial

6.40

7.19

12.15

4.45

4.58

GW Pharmaceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
PB Ratio	Get a 7-Day Free Trial															3.78	5.17	3.73	4.58	8.82

Competitive Comparison of GW Pharmaceuticals's PB Ratio

For the Drug Manufacturers - General subindustry, GW Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GW Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GW Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where GW Pharmaceuticals's PB Ratio falls into.

GW Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

GW Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Mar. 2021)
	=	17.00	/	1.946
	=	8.74

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

GW Pharmaceuticals (OTCPK:GWPRF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

GW Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of GW Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

GW Pharmaceuticals (GW Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GW Pharmaceuticals PLC (OTCPK:GWPRF) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sovereign House, Chivers Way, Vision Park, Histon, Cambridge, GBR, CB24 9BZ

Website

http://www.gwpharm.com

GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.